paritaprevir

inhibits HCV NS3 protease

Also Known As:

(2R,6S,12Z,13aS,14aR,16aS)- N- (cyclopropylsulfonyl)- 6- (5- methylpyrazin- 2- carboxamido)- 5,16- dioxo- 2- (phenanthridin- 6- yloxy)- 1,2,3,6,7,8,9,10,11,13a,14,15,16,16atetradecahydrocyclopropa(E)pyrrolo(1,2- a)(1,4)diazacyclopentadecine- 14a(5H)- carboxamide; ABT 450; ABT-450; ABT450; paritaprevir dihydrate; paritaprevir hydrate; veruprevir; veruprevir anhydrous

Organic Chemicals: 140
- Amides: 2487
  - Sulfonamides: 2855
    - paritaprevir: 290
  - Lactams: 2278
    - Macrocyclic Lactams: 28
      - paritaprevir: 290
- Hydrocarbons: 1726
  - Cyclic Hydrocarbons: 96
    - Alicyclic Hydrocarbons: 1
      - Cycloparaffins: 6
        Cyclopropanes: 9
        paritaprevir: 290
- Sulfur Compounds: 283
  - Sulfones: 537
    - Sulfonamides: 2855
      - paritaprevir: 290
Amino Acids, Peptides, and Proteins: 1
- Amino Acids: 31329
  - Cyclic Amino Acids: 3
    - Imino Acids: 11
      - Proline: 3465
        paritaprevir: 290
Polycyclic Compounds: 7
- Macrocyclic Compounds: 16
  - Macrocyclic Lactams: 28
    - paritaprevir: 290

Nathan Grunow Selected Research

Nathan Grunow Research Topics

Disease

Drug/Important Bio-Agent (IBA)

Therapy/Procedure